Tioga Pharmaceuticals
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). (NCT07042516) | Tioga Pharmaceuticals | 2025-08-13 |
| Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis (NCT02475447) | Tioga Pharmaceuticals | 2015-07-01 |
| A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers (NCT01380561) | Tioga Pharmaceuticals | 2011-06-01 |
| Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) (NCT01100684) | Tioga Pharmaceuticals | 2010-05-01 |
| Asimadoline for the Treatment of Post-Operative Ileus (NCT00443040) | Tioga Pharmaceuticals | 2007-01-01 |
| Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome (NCT00454688) | Tioga Pharmaceuticals | 2006-08-01 |
Track Tioga Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.